MYC and neuroblastoma: Histology of the tumor revealed an undifferentiated stroma-poor NB Sano[7] with MYC-N amplification (20–40 copies) and 1p36 deletion establishing the diagnosis of a high risk stage 4 NB Monclair[8] in an infant less than twelve months of age.